A carregar...
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Immunotherapy has shifted the clinical paradigm of cancer management. However, despite promising initial progress, immunotherapeutic approaches to cancer still suffer from relatively low response rates and the possibility of severe side effects, likely due to the low inherent immunogenicity of tumor...
Na minha lista:
| Publicado no: | Adv Sci (Weinh) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7709995/ https://ncbi.nlm.nih.gov/pubmed/33304763 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/advs.202002365 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|